Russell Hales, MD
Radiation Oncology · Baltimore, MDNPI 1033255138
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,250 of the $6,552 with a category attached, or 95.4%. AstraZeneca accounts for 62.2% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2023 at $3,964 and has fallen 97.2% since, to $112 in 2024.
Across 5 payments — averaging $1310.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$4K
- E.r. Squibb & Sons, L.L.C.$2K
Across 1 payment — averaging $27,723 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$28K
What the payments were for
- Consulting fees$6,25095%
- Food & beverage$3025%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 4 | $4,077 |
| E.r. Squibb & Sons, L.L.C. | 1 | $2,475 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPDIVO$2,475
How this compares
$6,552 in reported general payments places this provider in the 85th percentile of 108 radiation oncology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 22 | $182 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Baltimore
- Sahaja AcharyaBaltimore$200K
- Arpit ChhabraBaltimore$97K
- Lawrence KleinbergBaltimore$34K
- Danny SongBaltimore$32K
- Jason MolitorisBaltimore$26K
- Kristin RedmondBaltimore$17K
- Avani RaoBaltimore$10K
- Amanda WalkerBaltimore$9K
- Christopher JohnsonBaltimore$7K
- Harry QuonBaltimore$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.